Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949490873> ?p ?o ?g. }
- W2949490873 endingPage "23" @default.
- W2949490873 startingPage "10" @default.
- W2949490873 abstract "New nucleoside analogues 14−17 based on a methylenecyclopropane structure were synthesized and evaluated for antiviral activity. Reaction of 2,3-dibromopropene (19) with adenine (18) led to bromoalkene 20, which was benzoylated to give N6,N6-dibenzoyl derivative 23. Attempts to convert 20 or 23 to bromocyclopropanes 21 and 22 by reaction with ethyl diazoacetate catalyzed by Rh2(OAc)4 were futile. By contrast, 2,3-dibromopropene (19) afforded smoothly (E)- and (Z)-dibromocyclopropane carboxylic esters 24 + 25. Alkylation of adenine (18) with 24 + 25 gave (E)- and (Z)-bromo derivatives 21 + 22. Base-catalyzed elimination of HBr resulted in the formation of (Z)- and (E)-methylenecyclopropanecarboxylic esters 26 + 27. More convenient one-pot alkylation−elimination of adenine (18) or 2-amino-6-chloropurine (30) with 24 + 25 afforded (Z)- and (E)-methylenecyclopropane derivatives 26 + 27 and 31 + 32. The Z-isomers were always predominant in these mixtures (Z/E ∼ 2/1). Reduction of 26 + 27 and 31 + 32 with DIBALH afforded (Z)- and (E)-methylenecyclopropane alcohols 14 + 16 and 33 + 34. The latter were resolved directly by chromatography. Compounds 14 + 16 were converted to N6-(dimethylamino)methylene derivatives 28 and 29 which were separated and deprotected to give 14 and 16. Reaction of 33 and 34 with HCO2H led to guanine analogues 15 and 17. The 1H NMR spectra of the Z-analogues 14 and 15 are consistent with an anti-like conformation of the nucleobases. By contrast, 1H NMR and IR spectra of bromo ester 21 are indicative of syn-conformation of adenine. Several Z-(hydroxymethyl)methylenecyclopropanes exhibited in vitro antiviral activity in micromolar or submicromolar range against human and murine cytomegalovirus (HCMV and MCMV), Epstein−Barr virus (EBV), human herpes virus 6 (HHV-6), varicella zoster virus (VZV), and hepatitis B virus (HBV). Analogues 14, 15, and 33 were the most effective agents against HCMV (IC50 1−2.1, 0.04−2.1, and 0.8−5.6 μM), MCMV (IC50 2.1, 0.3, and 0.3 μM) and EBV in H-1 (IC50 0.2, 0.3, and 0.7 μM) and Daudi cells (IC50 3.2, 5.6, and 1.2 μM). Adenine analogue 14 was active against HBV (IC50 2 μM), VZV (IC50 2.5 μM), and HHV-6 (IC50 14 μM). Synadenol (14) and the E-isomer (16) were substrates of moderate efficiency for adenosine deaminase from calf intestine. The E-isomer 16 was more reactive than Z-isomer 14. The deamination of 14 effectively stopped at 50% conversion. Synadenol (14) was also deaminated by AMP deaminase from aspergillus sp." @default.
- W2949490873 created "2019-06-27" @default.
- W2949490873 creator A5000085395 @default.
- W2949490873 creator A5004932382 @default.
- W2949490873 creator A5006348104 @default.
- W2949490873 creator A5007051212 @default.
- W2949490873 creator A5015242485 @default.
- W2949490873 creator A5027090095 @default.
- W2949490873 creator A5034322715 @default.
- W2949490873 creator A5050788707 @default.
- W2949490873 creator A5052420009 @default.
- W2949490873 creator A5076281231 @default.
- W2949490873 date "1998-01-01" @default.
- W2949490873 modified "2023-10-03" @default.
- W2949490873 title "(<i>Z</i>)- and (<i>E</i>)-2-((Hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New Nucleoside Analogues with a Broad-Spectrum Antiviral Activity" @default.
- W2949490873 cites W1968008788 @default.
- W2949490873 cites W1968075183 @default.
- W2949490873 cites W1972770998 @default.
- W2949490873 cites W1997322450 @default.
- W2949490873 cites W1997428853 @default.
- W2949490873 cites W1998521798 @default.
- W2949490873 cites W2003813773 @default.
- W2949490873 cites W2008614195 @default.
- W2949490873 cites W2016165525 @default.
- W2949490873 cites W2020331126 @default.
- W2949490873 cites W2024682383 @default.
- W2949490873 cites W2029533112 @default.
- W2949490873 cites W2034451071 @default.
- W2949490873 cites W2054047850 @default.
- W2949490873 cites W2070799290 @default.
- W2949490873 cites W2078963845 @default.
- W2949490873 cites W2090627191 @default.
- W2949490873 cites W2165260654 @default.
- W2949490873 cites W2330785095 @default.
- W2949490873 cites W280694366 @default.
- W2949490873 cites W2949263344 @default.
- W2949490873 cites W2949792458 @default.
- W2949490873 cites W2951227540 @default.
- W2949490873 cites W2952468402 @default.
- W2949490873 cites W4211254635 @default.
- W2949490873 cites W1978754899 @default.
- W2949490873 cites W1999529894 @default.
- W2949490873 doi "https://doi.org/10.1021/jm9705723" @default.
- W2949490873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9438017" @default.
- W2949490873 hasPublicationYear "1998" @default.
- W2949490873 type Work @default.
- W2949490873 sameAs 2949490873 @default.
- W2949490873 citedByCount "99" @default.
- W2949490873 countsByYear W29494908732012 @default.
- W2949490873 countsByYear W29494908732013 @default.
- W2949490873 countsByYear W29494908732014 @default.
- W2949490873 countsByYear W29494908732016 @default.
- W2949490873 countsByYear W29494908732018 @default.
- W2949490873 countsByYear W29494908732019 @default.
- W2949490873 countsByYear W29494908732020 @default.
- W2949490873 countsByYear W29494908732021 @default.
- W2949490873 countsByYear W29494908732022 @default.
- W2949490873 countsByYear W29494908732023 @default.
- W2949490873 crossrefType "journal-article" @default.
- W2949490873 hasAuthorship W2949490873A5000085395 @default.
- W2949490873 hasAuthorship W2949490873A5004932382 @default.
- W2949490873 hasAuthorship W2949490873A5006348104 @default.
- W2949490873 hasAuthorship W2949490873A5007051212 @default.
- W2949490873 hasAuthorship W2949490873A5015242485 @default.
- W2949490873 hasAuthorship W2949490873A5027090095 @default.
- W2949490873 hasAuthorship W2949490873A5034322715 @default.
- W2949490873 hasAuthorship W2949490873A5050788707 @default.
- W2949490873 hasAuthorship W2949490873A5052420009 @default.
- W2949490873 hasAuthorship W2949490873A5076281231 @default.
- W2949490873 hasConcept C104317684 @default.
- W2949490873 hasConcept C155647269 @default.
- W2949490873 hasConcept C161790260 @default.
- W2949490873 hasConcept C164361826 @default.
- W2949490873 hasConcept C178790620 @default.
- W2949490873 hasConcept C185592680 @default.
- W2949490873 hasConcept C2776543447 @default.
- W2949490873 hasConcept C2778301229 @default.
- W2949490873 hasConcept C2780591741 @default.
- W2949490873 hasConcept C2780815526 @default.
- W2949490873 hasConcept C512185932 @default.
- W2949490873 hasConcept C552990157 @default.
- W2949490873 hasConcept C55493867 @default.
- W2949490873 hasConcept C61234307 @default.
- W2949490873 hasConcept C66974803 @default.
- W2949490873 hasConcept C71240020 @default.
- W2949490873 hasConceptScore W2949490873C104317684 @default.
- W2949490873 hasConceptScore W2949490873C155647269 @default.
- W2949490873 hasConceptScore W2949490873C161790260 @default.
- W2949490873 hasConceptScore W2949490873C164361826 @default.
- W2949490873 hasConceptScore W2949490873C178790620 @default.
- W2949490873 hasConceptScore W2949490873C185592680 @default.
- W2949490873 hasConceptScore W2949490873C2776543447 @default.
- W2949490873 hasConceptScore W2949490873C2778301229 @default.
- W2949490873 hasConceptScore W2949490873C2780591741 @default.
- W2949490873 hasConceptScore W2949490873C2780815526 @default.
- W2949490873 hasConceptScore W2949490873C512185932 @default.
- W2949490873 hasConceptScore W2949490873C552990157 @default.
- W2949490873 hasConceptScore W2949490873C55493867 @default.